HARKE Pharma GmbH
HARKE Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1992, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a commitment to innovation and quality, HARKE Pharma offers a diverse portfolio that caters to both generic and specialty markets. Their unique approach to product development and stringent quality control measures have earned them a strong market position and recognition for excellence in the industry. HARKE Pharma continues to expand its global footprint, driven by a dedication to improving healthcare outcomes and meeting the evolving needs of patients worldwide.
DitchCarbon Score
How does HARKE Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HARKE Pharma GmbH's score of 9 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HARKE Pharma GmbH's reported carbon emissions
HARKE Pharma GmbH, headquartered in India, currently does not have specific carbon emissions data available for recent years. As a current subsidiary, it inherits its climate commitments and emissions data from its parent organization, Harke Pharma GmbH. Despite the absence of concrete emissions figures, HARKE Pharma GmbH is committed to addressing climate change through various initiatives. However, there are no documented reduction targets or specific climate pledges outlined at this time. As part of the pharmaceutical industry, HARKE Pharma GmbH is positioned within a sector increasingly focused on sustainability and reducing carbon footprints. The company is expected to align with industry standards and best practices in climate action, although specific details on their initiatives or targets remain unspecified. Overall, while HARKE Pharma GmbH has not disclosed specific emissions data or reduction commitments, its affiliation with a larger corporate family suggests a potential for future alignment with broader sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HARKE Pharma GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
